Purpose To report the long-term functional and anatomical outcome of full macular translocation (FMT) in eyes with neovascular age-related macular degeneration (AMD) following photodynamic therapy (PDT). Methods Twelve eyes of 12 consecutive patients with neovascular AMD who were PDT-nonresponders and underwent FMT were analysed. Best-corrected visual acuity (BCVA) measurement, fundus photography, and fluorescein angiography at baseline and at follow-up examinations in 3 months intervals were performed. Primary end point was change of BCVA from baseline to last visit. Results Totally 12 eyes of 12 patients were analysed. Mean time interval between the last PDT and FMT was 3.7 months (range 1-10 months). Mean follow-up after FMT was 25.6 months.
Introduction
Age-related macular degeneration (AMD) is the major cause for legal blindness in the industrialised countries. 1 Photodynamic therapy (PDT) using verteporfin (Visudyne; CIBA Vision Corp., Duluth, GA, USA) was proven to be beneficial for patients with predominantly classic subfoveal CNV in AMD. 2 But a considerable amount of patients do not respond to the PDT.
Full macular translocation (FMT), which was first described by Machemer and Steinhorst, is a therapeutical option in selected cases of neovascular AMD. [3] [4] [5] [6] [7] [8] [9] The purpose of this retrospective case study is to elucidate the long-term functional and morphological outcome of PDT-nonresponders who had undergone FMT in neovascular AMD.
Materials and methods
Twelve eyes of 12 patients with neovascular AMD treated between October 2001 and June 2005 at the Center for Ophthalmology in Tuebingen were included in this retrospective study. All patients had primary PDT and underwent FMT because of worsening of the vision following PDT. Ophthalmic examination included standardised best-corrected visual acuity (BCVA) measurement with ETDRS chart, fundus photography, and fluorescein angiography at baseline and at follow-up examinations in 3 months intervals.
Primary end point was change of BCVA from baseline to last visit.
Visual acuity Snellen equivalents were converted into logMAR units for statistical analysis.
PDT was performed according to the standard protocol described previously. 2 The FMT was performed by one surgeon (KUB-S). A standard three port pars plana vitrectomy was carried out. After having removed the vitreous body and a small retinotomy at the inferior aquator, retinal detachment was created by injection of balanced salt solution by introducing a cannula through the retinotomy in the subretinal space. Following a 3601 retinotomy, the temporal part of the detached retina was rolled over the papilla and the CNV was removed. The retina was reattached by perfluorocarbon liquid and rotated superiorly in a region of healthy retinal pigment epithelium. Thereafter, a laser cerclage was performed and the retinotomy was surrounded with laser. Vitreous cavity was finally filled with silicone oil. Muscle surgery was either performed together with the FMT (two eyes) or in a second step together with the removal of the silicone oil (nine eyes). In one case no muscle surgery was carried out, because of lack of disturbing diplopia.
Results
Twelve eyes of 12 patients were analysed (five men and seven women). Their age ranged from 66 to 93 years (mean age 76 years). Before the first PDT, five eyes showed a subfoveal predominantly classic CNV. Four eyes had a subfoveal occult CNV ( Figure 1 ). Two eyes had a retinal angiomatous proliferation (RAP), one in a juxtafoveal localisation, and the other one in a subfoveal localisation. One eye had a subfoveal minimally classic CNV.
Before the FMT, CNV lesion type had changed in some eyes: Of the five predominantly classic CNV, three remained unchanged, one eye showed a large macular haemorrhage, and one eye developed a minimally classic CNV. Three of the four eyes with occult CNV developed submacular haemorrhage that was larger than the CNV and one eye developed a minimally classic CNV (Figure 2 ). Two eyes with RAP lesion maintained this lesion type. The eye with the subfoveal minimally classic CNV developed macular haemorrhage that was larger than the CNV.
Follow-up ranged between 8 and 41 months (mean 25.6 months) ( Table 1 ). Only two eyes had not completed the 1-year follow-up. In one patient, the examination was not possible because of the reduced general condition. The other patient was lost to follow-up.
Ten eyes had a follow-up of at least 12 months. Six eyes had a follow-up of at least 24 months and four eyes were followed up for 36 months or longer.
Mean Time interval between the last PDT and FMT varied between 1 and 10 months (mean: 3.7 months). The number of PDT ranged between 1 and 3 sessions (mean 1.7 sessions). Comparison of the last BCVA of eyes receiving one PDT and eyes being treated by more than one PDT showed a decrease of the mean BCVA by 1 ETDRS line in the first group and an improvement by 2 lines in the second group.
Recurrence of the CNV was seen in one of the 12 eyes after FMT. The recurrent CNV was extrafoveal and treated by laser photocoagulation and intravitreal triamcinolone injection. Chronic macular oedema developed in four of the 12 eyes. No retinal detachment was seen. No patient complained about disturbing diplopia.
One eye developed vitreous haemorrhage and ocular hypotonia after silicone oil removal. Following a repeat of silicone oil installation, the eye stabilised, and intraocular pressure was normal after silicone oil removal.
Discussion
In this study, the majority of the eyes of the PDT-nonresponders with neovascular AMD had experienced a stabilisation or improvement of visual acuity in a mean follow-up period of 2 years who underwent FMT.
Park and Toth 5 analysed a group of eight eyes in PDT-nonresponders having undergone FMT. Similar to our results, vision was stabilised in most of cases with a mean visual acuity improvement of six letters. They did not see recurrent CNV in a mean follow-up period of 10 months. In half of the eyes cystoid macular oedema was detected, similar to our observation. One eye developed a retinal detachment. 5 Mirshahi et al 6 reported of a case of FMT following PDT. In a follow-up period of 9 months, visual acuity In our study, one eye experienced recurrence of CNV 13 months after FMT unlike the study of Park and Toth. 5 This may be on the basis of the short follow-up period of about 10 months in the latter.
Recurrent CNV after FMT was observed in 3-8 % of eyes. [7] [8] [9] Complication related to FMT included retinal detachment, macular oedema, persistent hypotony, and disturbing diplopia. [7] [8] [9] Our results showed a slightly more favourable visual outcome for patients receiving more than one PDT session before the FMT, differing from the results of Park and Toth. 5 However, the small sample size analysed in both studies makes a reasonable statement difficult.
The reported increased adhesion of the CNV to the overlying retina after PDT was not noted in our study. Adhesions in the macular area may be possible because of subretinal fibrosis or chorioretinal connections in RAP rather than an effect of PDT.
There are several limitations of our case series. Besides the retrospective character and small number of cases, possible selection bias for the surgery should be mentioned.
FMT is a therapeutic option in patients who are PDT-nonresponders with a long-term lasting effect on stabilisation or improving the visual acuity. However, surgery-related complications must be kept in mind and need to be discussed with the candidates.
